Cargando…

Cellular origin and pathophysiology of chronic lymphocytic leukemia

The cellular origin of chronic lymphocytic leukemia (CLL) is still debated, although this information is critical to understanding its pathogenesis. Transcriptome analyses of CLL and the main normal B cell subsets from human blood and spleen revealed that immunoglobulin variable region (IgV) gene un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seifert, Marc, Sellmann, Ludger, Bloehdorn, Johannes, Wein, Frederik, Stilgenbauer, Stephan, Dürig, Jan, Küppers, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501361/ https://www.ncbi.nlm.nih.gov/pubmed/23091163 http://dx.doi.org/10.1084/jem.20120833

Ejemplares similares

DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy
por: Yosifov, Deyan Yordanov, et al.
Publicado: (2020)

Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
por: Zapatka, Marc, et al.
Publicado: (2021)

Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
por: Göbel, Maria, et al.
Publicado: (2013)

Advances in treating chronic lymphocytic leukemia
por: Tausch, Eugen, et al.
Publicado: (2014)

Telomere Dysfunction in Chronic Lymphocytic Leukemia
por: Jebaraj, Billy Michael Chelliah, et al.
Publicado: (2021)

Refractory chronic lymphocytic leukemia – new therapeutic strategies
por: Schnaiter, Andrea, et al.
Publicado: (2010)

The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia
por: Rusyn, Lisa, et al.
Publicado: (2022)

Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
por: Scheffold, Annika, et al.
Publicado: (2020)

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients
por: Bloehdorn, Johannes, et al.
Publicado: (2021)

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group
por: Jaramillo, Sonia, et al.
Publicado: (2019)

Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
por: Huber, Henriette, et al.
Publicado: (2017)

Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia
por: Hanoun, Maher, et al.
Publicado: (2012)

SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
por: Johansson, Patricia, et al.
Publicado: (2018)

Nucleosome repositioning in chronic lymphocytic leukemia
por: Piroeva, Kristan V., et al.
Publicado: (2023)

Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia
por: Correia, Rodolfo Patussi, et al.
Publicado: (2014)

The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia
por: Gutjahr, Julia Christine, et al.
Publicado: (2015)

Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL)
por: Sitlinger, Andrea, et al.
Publicado: (2021)

Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing
por: Johansson, Patricia, et al.
Publicado: (2020)

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
por: Campo, Elias, et al.
Publicado: (2018)

Molecular footprints of a germinal center derivation of human IgM(+)(IgD(+))CD27(+) B cells and the dynamics of memory B cell generation
por: Seifert, Marc, et al.
Publicado: (2009)

Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
por: Johansson, Patricia, et al.
Publicado: (2016)

Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia
por: Wei, Quan-Xiang, et al.
Publicado: (2013)

Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo
por: Lutzny, Gloria, et al.
Publicado: (2013)

Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
por: Johansson, Patricia, et al.
Publicado: (2022)

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
por: Bloehdorn, Johannes, et al.
Publicado: (2021)

Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia
por: Schulze-Edinghausen, Lena, et al.
Publicado: (2019)

CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo
por: Dampmann, Maria, et al.
Publicado: (2020)

Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
por: Johansson, Patricia, et al.
Publicado: (2023)

Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL
por: Wierzbinska, Justyna A., et al.
Publicado: (2020)

Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia
por: Faehling, Sebastian, et al.
Publicado: (2023)

Systematic memory B cell archiving and random display shape the human splenic marginal zone throughout life
por: Kibler, Artur, et al.
Publicado: (2021)

EOMES is essential for antitumor activity of CD8(+) T cells in chronic lymphocytic leukemia
por: Llaó-Cid, Laura, et al.
Publicado: (2021)

Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)
por: Turki, Amin T., et al.
Publicado: (2017)

Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks
por: Mallm, Jan‐Philipp, et al.
Publicado: (2019)

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in E-TCL1 mice
por: Hanna, Bola S., et al.
Publicado: (2020)

Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
por: Cramer, Paula, et al.
Publicado: (2020)

The Splenic Marginal Zone in Children Is Characterized by a Subpopulation of CD27-Negative, Lowly IGHV-Mutated B Cells
por: Kibler, Artur, et al.
Publicado: (2022)

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial
por: Bühler, A, et al.
Publicado: (2016)

Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations
por: Peveling-Oberhag, Jan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qe4ugqti2699tk9io4q3atnt6k